Request Demo
Last update 31 Jan 2026
BPB-101
Last update 31 Jan 2026
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms BPB-101双抗, BPB 101, BPB-101 + [1] |
Target |
Action inhibitors |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors), TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with BPB-101NCT05869240
A Phase I/II, Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPB-101 in Patients With Advanced Malignant Solid Tumors.
100 Clinical Results associated with BPB-101
Login to view more data
100 Translational Medicine associated with BPB-101
Login to view more data
100 Patents (Medical) associated with BPB-101
Login to view more data
100 Deals associated with BPB-101
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | China | 16 May 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 04 May 2023 | |
| Bladder Cancer | Phase 2 | China | 04 May 2023 | |
| Breast Cancer | Phase 2 | China | 04 May 2023 | |
| Colorectal Cancer | Phase 2 | China | 04 May 2023 | |
| Endometrial Carcinoma | Phase 2 | China | 04 May 2023 | |
| Esophageal Carcinoma | Phase 2 | China | 04 May 2023 | |
| Melanoma | Phase 2 | China | 04 May 2023 | |
| Non-Small Cell Lung Cancer | Phase 2 | China | 04 May 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 19 | favbpzazyy(dbmuhwzfzq) = wcjdpjzxwj idiqlmogab (nwvypegeeu ) View more | Positive | 05 Dec 2025 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free